Is Tremelimumab Beneficial in Advanced Melanoma? Reply

被引：6

作者：

Ribas, Antoni ^{[1
,2
]}

Hauschild, Axel ^{[3
]}

Kefford, Richard ^{[4
,5
]}

机构：

[1] Univ Calif Los Angeles, Los Angeles, CA 90047 USA

[2] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA

[3] Univ Kiel, Kiel, Germany

[4] Univ Sydney, Westmead Inst Canc Res, Westmead Hosp, Sydney, NSW 2006, Australia

[5] Univ Sydney, Melanoma Inst Australia, Westmead Hosp, Sydney, NSW 2006, Australia

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 22期

关键词：

METASTATIC MELANOMA; PHASE-II; TRIAL;

D O I：

10.1200/JCO.2013.50.2120

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：2836 / 2837

页数：3

共 8 条

[1]

Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma [J].

Camacho, Luis H. ;

Antonia, Scott ;

Sosman, Jeffrey ;

Kirkwood, John M. ;

Gajewski, Thomas F. ;

Redman, Bruce ;

Pavlov, Dmitri ;

Bulanhagui, Cecile ;

Bozon, Viviana A. ;

Gomez-Navarro, Jesus ;

Ribas, Antoni .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) :1075-1081

[2]

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[3]

Phase II Trial of Tremelimumab (CP-675,206) in Patients with Advanced Refractory or Relapsed Melanoma [J].

Kirkwood, John M. ;

Lorigan, Paul ;

Hersey, Peter ;

Hauschild, Axel ;

Robert, Caroline ;

McDermott, David ;

Marshall, Margaret A. ;

Gomez-Navarro, Jesus ;

Liang, Jane Q. ;

Bulanhagui, Cecile A. .

CLINICAL CANCER RESEARCH, 2010, 16 (03) :1042-1048

[4]

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study [J].

O'Day, S. J. ;

Maio, M. ;

Chiarion-Sileni, V. ;

Gajewski, T. F. ;

Pehamberger, H. ;

Bondarenko, I. N. ;

Queirolo, P. ;

Lundgren, L. ;

Mikhailov, S. ;

Roman, L. ;

Verschraegen, C. ;

Humphrey, R. ;

Ibrahim, R. ;

de Pril, V. ;

Hoos, A. ;

Wolchok, J. D. .

ANNALS OF ONCOLOGY, 2010, 21 (08) :1712-1717

[5]

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma [J].

Ribas, Antoni ;

Kefford, Richard ;

Marshall, Margaret A. ;

Punt, Cornelis J. A. ;

Haanen, John B. ;

Marmol, Maribel ;

Garbe, Claus ;

Gogas, Helen ;

Schachter, Jacob ;

Linette, Gerald ;

Lorigan, Paul ;

Kendra, Kari L. ;

Maio, Michele ;

Trefzer, Uwe ;

Smylie, Michael ;

McArthur, Grant A. ;

Dreno, Brigitte ;

Nathan, Paul D. ;

Mackiewicz, Jacek ;

Kirkwood, John M. ;

Gomez-Navarro, Jesus ;

Huang, Bo ;

Pavlov, Dmitri ;

Hauschild, Axel .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) :616-622

[6]

Clinical Development of the Anti-CTLA-4 Antibody Tremelimumab [J].

Ribas, Antoni .

SEMINARS IN ONCOLOGY, 2010, 37 (05) :450-454

[7]

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma [J].

Robert, Caroline ;

Thomas, Luc ;

Bondarenko, Igor ;

O'Day, Steven ;

Weber, Jeffrey ;

Garbe, Claus ;

Lebbe, Celeste ;

Baurain, Jean-Francois ;

Testori, Alessandro ;

Grob, Jean-Jacques ;

Davidson, Neville ;

Richards, Jon ;

Maio, Michele ;

Hauschild, Axel ;

Miller, Wilson H., Jr. ;

Gascon, Pere ;

Lotem, Michal ;

Harmankaya, Kaan ;

Ibrahim, Ramy ;

Francis, Stephen ;

Chen, Tai-Tsang ;

Humphrey, Rachel ;

Hoos, Axel ;

Wolchok, Jedd D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2517-2526

[8]

Is Tremelimumab Beneficial in Advanced Melanoma? [J].

Wilson, Kenneth S. ;

Kotb, Rami .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (22) :2835-2836

← 1 →